Compare OGN & IPGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | IPGP |
|---|---|---|
| Founded | 1923 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 4.7B |
| IPO Year | 2020 | 2000 |
| Metric | OGN | IPGP |
|---|---|---|
| Price | $6.35 | $114.04 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $11.75 | ★ $131.40 |
| AVG Volume (30 Days) | ★ 3.1M | 361.5K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.30% | N/A |
| EPS Growth | N/A | ★ 117.85 |
| EPS | 0.72 | ★ 0.73 |
| Revenue | ★ $6,216,000,000.00 | $1,003,777,000.00 |
| Revenue This Year | $0.42 | $12.18 |
| Revenue Next Year | $1.67 | $8.44 |
| P/E Ratio | ★ $8.53 | $158.24 |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $5.69 | $48.59 |
| 52 Week High | $14.25 | $155.82 |
| Indicator | OGN | IPGP |
|---|---|---|
| Relative Strength Index (RSI) | 46.51 | 47.09 |
| Support Level | $6.18 | $75.58 |
| Resistance Level | $7.87 | $131.20 |
| Average True Range (ATR) | 0.26 | 6.74 |
| MACD | 0.06 | -1.03 |
| Stochastic Oscillator | 79.17 | 32.34 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, laser and non-laser systems, fiber amplifiers, diode lasers, and related optical components. Its products are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. The company sells its products globally to original equipment manufacturers (OEMs), system integrators, and end users. Additionally, it manufactures complementary products used with its lasers, including optical delivery cables, fiber couplers, beam switches, optical processing heads, in-line sensors, and chillers. Geographically, the company generates maximum revenue from North America, followed by China, Japan, Germany, and other markets.